Plaisance Capital Management
North America, Massachusetts, United States, Natick
Description
Plaisance Capital Management identifies and invests in biotechnology startups.
Investor Profile
Plaisance Capital Management has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 10% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, Canada, China.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series A (30%)
- Series B (30%)
- Seed (30%)
- Series C (10%)
Country Focus
- United States (80%)
- Canada (10%)
- China (10%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical
- Health Diagnostics
- Medical Device
- Oncology
- Therapeutics
- Manufacturing
- Home Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.